BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7314053)

  • 1. Coagulation and fibrinolysis study in systemic lupus erythematosus: haematological, urinary and tissue parameters.
    Stratta P; Canavese C; Valmaggia P; Rotunno M; Levi E; Bulla A; Vercellone A
    Thromb Haemost; 1981 Oct; 46(3):575-80. PubMed ID: 7314053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Case of systemic lupus erythematosus associated with disseminated intravascular coagulation (DIC); with special reference to the relation between autoimmune phenomena and coagulation-fibrinolysis reactions].
    Shinmyozu K; Ichinose A; Okada A; Maruyama I; Igata A
    Nihon Naika Gakkai Zasshi; 1983 Jul; 72(7):947-54. PubMed ID: 6663182
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intravascular blood coagulation and immune complex inflammation in patients with systemic lupus erythematosus].
    Nasonova VA; Saĭkovskaia TV
    Ter Arkh; 1985; 57(7):91-8. PubMed ID: 2931851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage.
    Angles-Cano E; Sultan Y; Clauvel JP
    J Lab Clin Med; 1979 Aug; 94(2):312-23. PubMed ID: 458249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic role of intravascular coagulation in immune diseases.
    Papilian M; Purice S; Niţă I; Tanaăseanu S
    Med Interne; 1977; 15(4):341-7. PubMed ID: 594617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disseminated intravascular coagulation].
    Levi M; de Jonge E; ten Cate H
    Ned Tijdschr Geneeskd; 2000 Mar; 144(10):470-5. PubMed ID: 10726156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation and fibrinolysis in individuals with advanced liver disease.
    Van Thiel DH; George M; Mindikoğlu AL; Baluch MH; Dhillon S
    Turk J Gastroenterol; 2004 Jun; 15(2):67-72. PubMed ID: 15334312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coagulation and acute disseminated lupus erythematosus. Apropos of 25 cases].
    Godeau P; Herreman G; Raby C; Levassor M
    Sem Hop; 1977 Mar; 53(10):609-12. PubMed ID: 194314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-fibrinogen antibody detected in a patient with systemic lupus erythematosus and disseminated intravascular coagulation].
    Ozaki Y; Kagawa H; Yasuzawa M; Yoshimura C; Shimizu T; Nomura S; Kitajima H; Kishimoto Y; Komiyama Y; Okamura A; Fukuhara S
    Rinsho Ketsueki; 1998 Jun; 39(6):436-41. PubMed ID: 9695672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations of the lupus-like inhibitor by-passing activity of platelets.
    Howard MA; Firkin BG
    Thromb Haemost; 1983 Dec; 50(4):775-9. PubMed ID: 6420922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated intravascular coagulation in a patient with systemic lupus erythematosus with lupus anticoagulant.
    Tanaka M; Kobayashi S; Tamura N; Hashimoto H; Hirose S
    Intern Med; 1993 Jun; 32(6):513-7. PubMed ID: 8241600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lupus nephropathy. Hematic, tissue and urinary signs of coagulation involvement].
    Stratta P; Canavese C; Dogliani M; Ragni R; Coppo R; Messina M; Rotunno M; Vercellone A
    Minerva Nefrol; 1981; 28(3):215-20. PubMed ID: 7329597
    [No Abstract]   [Full Text] [Related]  

  • 17. Disseminated intravascular coagulation: What's new?
    Levi M
    Crit Care Clin; 2005 Jul; 21(3):449-67. PubMed ID: 15992667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of antithrombin administration in the acute phase of burn injury.
    Lavrentieva A; Kontakiotis T; Bitzani M; Parlapani A; Thomareis O; Scourtis H; Tsotsolis N; Lazaridis L; Giala MA
    Thromb Haemost; 2008 Aug; 100(2):286-90. PubMed ID: 18690349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The thrombocyte link in blood-coagulation homeostasis in patients with systemic lupus erythematosus].
    Vas'kova NG
    Vrach Delo; 1990 Nov; (11):51-3. PubMed ID: 2098984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lupus anticoagulant: an increasingly used marker].
    Castañeda Sanz S; Herrero-Beaumont G; Tornero Molina J; Aguado García JM; Outeiriño J
    Rev Clin Esp; 1985 Jun; 177(1):1-6. PubMed ID: 3929341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.